Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Integrative Analysis of ovarian cancer cell behavior reveals a miRNA signature associated with Intrinsic Platinum Resistance in ovarian cancer.

ABSTRACT: Integrative Analysis of ovarian cancer cell behavior reveals a miRNA signature associated with Intrinsic Platinum Resistance in ovarian cancer.

PROVIDER: PRJNA473131 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7218270.fastq.gz	Fastqsanger.gz
	SRR7218280.fastq.gz	Fastqsanger.gz
	SRR7218290.fastq.gz	Fastqsanger.gz
	SRR7218261.fastq.gz	Fastqsanger.gz
	SRR7218271.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

Project description:FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy

| PRJNA530129 | ENA

FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy [ID8 and ID8-IP / KMF cells]

Project description:Gene copy number changes, cancer stem cell (CSC) increases, and platinum chemotherapy resistance contribute to poor prognosis in patients with recurrent high grade serous ovarian cancer (HGSOC). CSC phenotypes involving Wnt-b-catenin and aldehyde dehydrogenase activities, platinum resistance, and tumor initiating frequency are here associated with spontaneous genetic gains, including genes encoding KRAS, MYC and FAK, in a new murine model of ovarian cancer (KMF). Noncanonical FAK signaling was sufficient to sustain human and KMF tumorsphere proliferation, CSC survival, and platinum resistance. Increased FAK tyrosine phosphorylation occurred in HGSOC patient tumors surviving neo-adjuvant platinum and paclitaxel chemotherapy and platinum resistant tumorspheres acquired FAK dependence for growth. Importantly, combining a pharmacologic FAK inhibitor with platinum overcame chemoresistance and triggered apoptosis in vitro and in vivo. Knockout, rescue, genomic and transcriptomic analyses collectively identified more than 400 genes regulated along a FAK/b-catenin/Myc axis impacting stemness and DNA repair in HGSOC, with 66 genes gained in a majority of Cancer Genome Atlas samples. Together, these results support combinatorial testing of FAK inhibitors for the treatment of recurrent ovarian cancer.

2019-07-01 | GSE129097 | GEO

RNA-Seq of treatment response of platinum sensitive and platinum resistant ovarian cancer cells

Project description:Resistance to platinum-based chemotherapy is a clinical challenge in the treatment of ovarian cancer (OC) and limits survival. Therefore, innovative drugs against platinum-resistance are urgently needed. Our therapeutic concept is based on the conjugation of two chemotherapeutic compounds to a monotherapeutic pro-drug, which is taken up by cancer cells and cleaved into active cytostatic metabolites. Here, we explore the activity of the duplex-prodrug 5-FdU-ECyd, covalently linking 2'-deoxy-5-fluorouridine (5-FdU) and 3'-C-ethynylcytidine (ECyd), on platinum-resistant OC cells. RNA-Sequencing was used for characterization of 5-FdU-ECyd treated platinum-sensitive A2780 and isogenic platinum-resistant A2780cis.

2018-02-22 | GSE98230 | GEO

Transcriptional profiling of platinum sensitive and platinum resistant high grade serous ovarian cancer samples

Project description:This study aims at correlating changes in the transcriptional state in high grade serous epithelial ovarian cancer (HGS-EOC) to the response to therapy, in particular the insurgence of resistance to platinum-based treatment.

2020-02-11 | E-MTAB-7083 | biostudies-arrayexpress

microRNA profiling of platinum sensitive and platinum resistant high grade serous ovarian cancer samples

Project description:This study aims at correlating changes in the microRNA state in high grade serous epithelial ovarian cancer (HGS-EOC) to the response to therapy, in particular the insurgence of resistance to platinum-based treatment.

2020-02-11 | E-MTAB-7084 | biostudies-arrayexpress

Integrative Analysis of ovarian cancer cell behavior reveals a miRNA signature associated with Intrinsic Platinum Resistance in ovarian cancer.

Project description:The aim of this study was to identify a set of miRNAs which are associated with chemotherapy resistance in ovarian cancer, and to evaluate if these miRNAs are enrich in small nanovesicles, called exosomes, released from ovarian cancer cells.

2021-05-25 | GSE114920 | GEO

6mer Seed toxicity and platinum resistance in ovarian cancer [DISE-37]

Project description:We demonstrate that 6mer seed toxicity plays a role in platinum resistance of ovarian cancer

2021-02-02 | GSE165147 | GEO

6mer Seed toxicity and platinum resistance in ovarian cancer [DISE-29]

Project description:We demonstrate that 6mer seed toxicity plays a role in platinum resistance of ovarian cancer

2021-02-02 | GSE165146 | GEO

6mer Seed toxicity and platinum resistance in ovarian cancer [DISE-26]

Project description:We demonstrate that 6mer seed toxicity plays a role in platinum resistance of ovarian cancer

2021-02-02 | GSE165145 | GEO

6mer Seed toxicity and platinum resistance in ovarian cancer [DISE-18]

Project description:We demonstrate that 6mer seed toxicity plays a role in platinum resistance of ovarian cancer